A comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine

被引：0
|
作者：
Gianfrancesco, FD
Wang, RH
White, RE
Yu, E
机构：
[1] HECON Assoc Inc, Montgomery Village, MD USA
[2] AstraZeneca Pharmaceut, Wilmington, DE USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64232-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：353 / 354
页数：2
相关论文
共 50 条
  • [41] Relationship between quetiapine dose and levels of mental health resource use among patients with schizophrenia or bipolar disorder
    Gianfrancesco, F
    Wang, RH
    Pesa, JA
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 269 - 270
  • [42] A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone
    Mintzer, JE
    Mullen, JA
    Sweitzer, DE
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1483 - 1491
  • [43] Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram
    Bohlken, Jens
    Riedel-Heller, Steffi
    Bauer, Michael
    Kostev, Karel
    [J]. PHARMACOPSYCHIATRY, 2021, 54 (03) : 126 - 130
  • [44] Comparison of risperidone, olanzapine and quetiapine for body weight, serum blood glucose and prolactin levels
    Chaudhry, H.
    Arshad, N.
    Niaz, S.
    Suleman, T.
    Mufti, K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S511 - S512
  • [45] Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA
    Yawen Jiang
    Weiyi Ni
    Justin J. McGinnis
    [J]. Clinical Drug Investigation, 2014, 34 : 491 - 499
  • [46] Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA
    Jiang, Yawen
    Ni, Weiyi
    McGinnis, Justin J.
    [J]. CLINICAL DRUG INVESTIGATION, 2014, 34 (07) : 491 - 499
  • [47] A comparison of the effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis
    Keefe, R
    Gu, HB
    Perkins, D
    McEvoy, J
    Hamer, R
    Lieberman, J
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S192 - S192
  • [48] Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder
    Spina, Edoardo
    D'Arrigo, Concetta
    Migliardi, Gaetana
    Santoro, Vincenza
    Muscatello, Maria Rosaria
    Mico, Umberto
    D'Amico, Giuseppina
    Perucca, Emilio
    [J]. THERAPEUTIC DRUG MONITORING, 2006, 28 (05) : 599 - 602
  • [49] Dyskinesia in naive children and adolescents treated with olanzapine, risperidone and quetiapine: three months follow up
    Merchan-Naranjo, J.
    Garcia-Amador, M.
    Leiva-Resino, M.
    Llorente, C.
    Tapia-Casellas, C.
    Giraldez, M.
    Fraguas, D.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S617 - S617
  • [50] Olanzapine versus risperidone in the treatment of schizophrenia: A mental health cost comparison in a managed care setting
    Sommers, S
    Lynch, F
    McFarland, B
    Muilenburg, N
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 354 - 355
12345